Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cyclacel Pharmaceuticals | CYCC | Apr 25, 2024 | 1.60 | -30.43 |
Cyclacel Pharmaceuticals Pref | CYCCP | Apr 25, 2024 | 10.00 | +24.84 |
Cyclerion Therapeutics | CYCN | Apr 25, 2024 | 3.04 | +9.75 |
Cyclo Therapeutics | CYTH | Apr 25, 2024 | 1.29 | -0.77 |
Cyngn | CYN | Apr 25, 2024 | 0.11 | +1.50 |
Cytek Biosciences | CTKB | Apr 25, 2024 | 5.63 | -0.53 |
Cytokinetics | CYTK | Apr 25, 2024 | 64.80 | -3.02 |
Cytomed Therapeutics | GDTC | Apr 25, 2024 | 2.20 | +2.33 |
CytomX Therapeutics | CTMX | Apr 25, 2024 | 1.60 | -1.84 |
Cytosorbents | CTSO | Apr 25, 2024 | 0.81 | -1.55 |
D-MARKET Electronic Services & Trading ADR | HEPS | Apr 25, 2024 | 1.39 | +0.72 |
D-Wave Quantum | QBTS | Apr 25, 2024 | 1.48 | -2.63 |
D.R. Horton | DHI | Apr 25, 2024 | 144.20 | -1.31 |
Dada Nexus ADR | DADA | Apr 25, 2024 | 2.00 | 0.00 |
Daily Journal | DJCO | Apr 25, 2024 | 347.00 | -1.70 |
Dakota Gold | DC | Apr 25, 2024 | 2.52 | +6.33 |
Daktronics | DAKT | Apr 25, 2024 | 9.29 | -2.72 |
DallasNews A | DALN | Apr 25, 2024 | 3.66 | +0.83 |
Dana | DAN | Apr 25, 2024 | 12.24 | -2.08 |
Danaher | DHR | Apr 25, 2024 | 245.80 | -1.84 |
Danaos | DAC | Apr 25, 2024 | 73.98 | +0.09 |
Danimer Scientific | DNMR | Apr 25, 2024 | 0.81 | +0.48 |
DAQO New Energy ADR | DQ | Apr 25, 2024 | 23.56 | -0.80 |
Darden Restaurants | DRI | Apr 25, 2024 | 156.54 | -0.04 |
Daré Bioscience | DARE | Apr 25, 2024 | 0.29 | +1.12 |
DarioHealth | DRIO | Apr 25, 2024 | 1.47 | -2.00 |
Darling Ingredients | DAR | Apr 25, 2024 | 45.26 | +4.94 |
Daseke | DSKE | Apr 25, 2024 | 8.29 | 0.00 |
Data I/O | DAIO | Apr 25, 2024 | 3.55 | +0.57 |
Data Storage | DTST | Apr 25, 2024 | 4.64 | -0.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.